M.M. Alberti

2.3k total citations
20 papers, 826 citations indexed

About

M.M. Alberti is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, M.M. Alberti has authored 20 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in M.M. Alberti's work include Diet and metabolism studies (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Diet, Metabolism, and Disease (4 papers). M.M. Alberti is often cited by papers focused on Diet and metabolism studies (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Diet, Metabolism, and Disease (4 papers). M.M. Alberti collaborates with scholars based in United Kingdom, Denmark and Australia. M.M. Alberti's co-authors include G.K. Gitau, DavidJ.A. Jenkins, ThomasM.S Wolever, A. R. Leeds, M.A. Gassull, Roy Taylor, Robert W. Wilkinson, Jean Claude Mbanya, Niels Møller and B. Nyholm and has published in prestigious journals such as The Lancet, American Journal of Clinical Nutrition and Hepatology.

In The Last Decade

M.M. Alberti

20 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.M. Alberti United Kingdom 13 413 278 201 191 144 20 826
F. Bruzzo France 12 244 0.6× 298 1.1× 320 1.6× 78 0.4× 103 0.7× 20 714
Taous Lassel France 12 392 0.9× 175 0.6× 273 1.4× 431 2.3× 143 1.0× 13 1.0k
J. M. Currie United Kingdom 7 165 0.4× 318 1.1× 179 0.9× 115 0.6× 209 1.5× 7 670
M Uusitupa Finland 10 360 0.9× 523 1.9× 365 1.8× 131 0.7× 197 1.4× 16 1.1k
Rogelio U. Almario United States 15 219 0.5× 224 0.8× 291 1.4× 74 0.4× 102 0.7× 21 839
Farihah Hj Suhaimi Malaysia 13 212 0.5× 228 0.8× 143 0.7× 106 0.6× 256 1.8× 27 847
Ettore Griffo Italy 11 192 0.5× 206 0.7× 112 0.6× 178 0.9× 72 0.5× 16 490
Fiona Campbell Australia 13 226 0.5× 214 0.8× 117 0.6× 134 0.7× 179 1.2× 19 1.0k
Amélie Charest Canada 16 170 0.4× 266 1.0× 455 2.3× 168 0.9× 89 0.6× 18 823
Claudia De Natale Italy 11 251 0.6× 208 0.7× 79 0.4× 83 0.4× 87 0.6× 13 515

Countries citing papers authored by M.M. Alberti

Since Specialization
Citations

This map shows the geographic impact of M.M. Alberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.M. Alberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.M. Alberti more than expected).

Fields of papers citing papers by M.M. Alberti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.M. Alberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.M. Alberti. The network helps show where M.M. Alberti may publish in the future.

Co-authorship network of co-authors of M.M. Alberti

This figure shows the co-authorship network connecting the top 25 collaborators of M.M. Alberti. A scholar is included among the top collaborators of M.M. Alberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.M. Alberti. M.M. Alberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Sidney C., Karen A. Donato, Jean‐Charles Fruchart, et al.. (2009). Association for the Study of Obesity Heart Federation; International Atherosclerosis Society; and International National Heart, Lung, and Blood Institute; American Heart Association; World International Diabetes Federation Task Force on Epidemiology and Prevention; Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the. 4 indexed citations
2.
Shaw, Jonathan E., Paul Zimmet, G.K. Gitau, & M.M. Alberti. (2005). Metabolic Syndrome—Do We Really Need a New Definition?. Metabolic Syndrome and Related Disorders. 3(3). 191–193. 6 indexed citations
3.
Daly, Mark, et al.. (2000). Acute fuel selection in response to high-sucrose and high-starch meals in healthy men. American Journal of Clinical Nutrition. 71(6). 1516–1524. 18 indexed citations
4.
Nyholm, B., L. Ørskov, Claus Højbjerg Gravholt, et al.. (1999). The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus. Metabolism. 48(7). 935–941. 85 indexed citations
5.
Gitau, G.K. & M.M. Alberti. (1998). Impaired glucose tolerance: what are the clinical implications?. Diabetes Research and Clinical Practice. 40. S3–S8. 45 indexed citations
7.
Møller, Niels, Søren Nielsen, B. Nyholm, et al.. (1996). Glucose turnover, fuel oxidation and forearm substrate exchange in patients with thyrotoxicosis before and after medical treatment. Clinical Endocrinology. 44(4). 453–459. 30 indexed citations
8.
Conlon, J. Michael, Loranne Agius, G.K. Gitau, M.M. Alberti, & Neil Hazon. (1994). Effects of Dogfish Urotensin II on Lipid Mobilization in the Fasted Dogfish, Scyliorhinus canicula. General and Comparative Endocrinology. 93(2). 177–180. 7 indexed citations
9.
Stewart, Murray, et al.. (1994). Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis. Hepatology. 19(2). 322–328. 26 indexed citations
10.
Collins, Veronica, Gary K. Dowse, Paul Zimmet, et al.. (1993). Serum insulin and ECG abnormalities suggesting coronary heart disease in the populations of Mauritius and Nauru: Cross-sectional and longitudinal associations. Journal of Clinical Epidemiology. 46(12). 1373–1393. 15 indexed citations
11.
McNeil, Calum J., et al.. (1990). Amperometric biosensor for rapid measurement of 3-hydroxybutyrate in undiluted whole blood and plasma. Analytica Chimica Acta. 237. 99–105. 24 indexed citations
12.
Tosh, David, G.K. Gitau, M.M. Alberti, & Loranne Agius. (1989). Clofibrate induces carnitine acyltransferases in periportal and perivenous zones of rat liver and does not disturb the acinar zonation of gluconeogenesis. Biochimica et Biophysica Acta (BBA) - General Subjects. 992(3). 245–250. 13 indexed citations
13.
Mbanya, Jean Claude, et al.. (1988). HYPERTENSION AND HYPERINSULINAEMIA: A RELATION IN DIABETES BUT NOT ESSENTIAL HYPERTENSION. The Lancet. 331(8588). 733–734. 103 indexed citations
14.
Alberti, M.M., et al.. (1987). Platelet dysfunction in homozygous beta-thalassemia. 24–28. 1 indexed citations
15.
Agius, Loranne, et al.. (1985). Effects of 2[5(4-chlorphenyl)pentyl]oxirane-2- carboxylate on fatty acid synthesis and fatty acid oxidation in isolated rat hepatocytes. Biochemical Pharmacology. 34(15). 2651–2654. 12 indexed citations
16.
Madsbad, Sten, O. K. Faber, Christian Binder, et al.. (1981). Diurnal profiles of intermediary metabolites in insulin-dependent diabetes and their relationship to different degrees of residual B-cell function. Acta Diabetologica. 18(2). 115–121. 9 indexed citations
17.
Gitau, G.K., M.M. Alberti, Desmond G. Johnston, et al.. (1981). Ketogenesis: regulatory factors in vivo. Biochemical Society Transactions. 9(1). 8–9. 5 indexed citations
18.
Whittaker, Jonathan, et al.. (1981). The effects of colchicine on insulin binding to isolated rat hepatocytes. Biochemical Society Transactions. 9(1). 88–89. 5 indexed citations
19.
Jenkins, DavidJ.A., R M R Taylor, R. Nineham, et al.. (1979). COMBINED USE OF GUAR AND ACARBOSE IN REDUCTION OF POSTPRANDIAL GLYCÆMIA. The Lancet. 314(8149). 924–927. 44 indexed citations
20.
Jenkins, DavidJ.A., A. R. Leeds, ThomasM.S Wolever, et al.. (1976). UNABSORBABLE CARBOHYDRATES AND DIABETES: DECREASED POST-PRANDIAL HYPERGLYCÆMIA. The Lancet. 308(7978). 172–174. 330 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026